Surgery Partners, Inc. · NASDAQ:SGRY
Surgery Partners — Q1 2026 Earnings Presentation
7 slides from Surgery Partners's earnings presentation, May 5, 2026
Slide 1: 1st Quarter 2026 Earnings Presentation
1st Quarter 2026 Earnings Presentation May 5, 2026
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements Statements contained in this presentation, other than statements of historical fact, are forward-looking statements. These statements can be identified by the use of words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “continues,”
Slide 3: First Quarter 2026 Highlights
First Quarter 2026 Highlights ~158k Consolidated Surgical Cases 0.6% Same-Facility Growth ~158k $810.9m Surgical Cases Net Revenue $811M Net Revenue 4.5% Y/Y Growth 4.4% Same-Facility Growth 15% Total Joint Growth YoY $102.3m Same-Facility ~65k Musculoskeletal¹ procedures Adjusted 4.4% Net Revenue 0
Slide 4: 2026 Financial Outlook
2026 Financial Outlook The Company Reaffirms its 2026 Full Year Guidance Revenue $3.35b - $3.45b Adjusted EBITDA $530m+ Organic Adjusted EBITDA Growth 4.2%+ Same-Facility Revenue Growth 3.0%+ Second Quarter 2026 Revenue Second Quarter 2026 Adjusted EBITDA 24.0% to 24.5% of mid-point of 23.0% to 23.5
Slide 5: 2026 Adjusted EBITDA Outlook Bridge from 2025
2026 Adjusted EBITDA Outlook Bridge from 2025 $ in millions 2025 Adjusted EBITDA $526 Annualize 2025 Acquisitions & Divestitures 9 Funding Annual Cash Incentive at Target (15) 2025 Normalized Performance $520 Provider Tax & Medicaid Pressures (8) Incremental Tariff Pressures (4) Organic Growth 22+ 2
Slide 6: Supplemental Non-GAAP Reconciliations
Supplemental Non-GAAP Reconciliations
Slide 7: Supplemental Non-GAAP Disclosures
Supplemental Non-GAAP Disclosures Pa ge 7 | SU RG E RY PARTNE RS We are not able to project components of 2026 Adjusted EBITDA outlook.